Within the Council’s purview are (1) the benefits and risks of drug products, (2) evidence-based use of medicines, (3) the application of drug information in practice, and (4) related matters.
2023-2024 Term
Name | Position | State |
Russel Roberts | Chair | Massachusetts |
Kate Ward | Vice Chair | Nevada |
Scott Bolesta | Member | Pennsylvania |
Rachel Bubik | Member | Minnesota |
Jerika Lam | Member | California |
Zahra Nasrazadani | Member | Kansas |
Kunal Patel | Member | Georgia |
Martha Roberts | Member | Rhode Island |
David Silva | Member | Connecticut |
Thomas Szymanski | Member | West Virginia |
Brittany Tschaen | Member | Delaware |
Frank Diaz | Technician | California |
Simran Chahal | Student | Tennessee |
Vickie Powell | Board Liaison | New York |
Vicki Basalyga | Secretary | Maryland |